Upregulation of miR-520b promotes ovarian cancer growth
Tóm tắt
Từ khóa
Tài liệu tham khảo
Zhao, 2014, Circulating MicroRNAs in gynecological malignancies: From detection to prediction, Exp Hematol Oncol, 3, 14, 10.1186/2162-3619-3-14
Rooth, 2013, Ovarian cancer: Risk factors, treatment and management, Br J Nurs, 22, S23, 10.12968/bjon.2013.22.Sup17.S23
Bristow, 2002, Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis, J Clin Oncol, 20, 1248, 10.1200/JCO.2002.20.5.1248
Winter-Roach, 2012, Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer, Cochrane Database Syst Rev, 3, CD004706
Winter-Roach, 2009, Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer, Cochrane Database Syst Rev: CD004706, 10.1002/14651858.CD004706.pub3
Hou, 2011, Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma, Cancer Cell, 19, 232, 10.1016/j.ccr.2011.01.001
Li, 2011, MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma, J Biol Chem, 286, 36677, 10.1074/jbc.M111.270561
Mendell, 2012, MicroRNAs in stress signaling and human disease, Cell, 148, 1172, 10.1016/j.cell.2012.02.005
Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634
Iorio, 2007, MicroRNA signatures in human ovarian cancer, Cancer Res, 67, 8699, 10.1158/0008-5472.CAN-07-1936
Resnick, 2009, The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, Gynecol Oncol, 112, 55, 10.1016/j.ygyno.2008.08.036
Chung, 2013, Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients, Int J Gynecol Cancer, 23, 673, 10.1097/IGC.0b013e31828c166d
Shapira, 2014, Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes, Br J Cancer, 110, 976, 10.1038/bjc.2013.795
Suryawanshi, 2013, Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer, Clin Cancer Res, 19, 1213, 10.1158/1078-0432.CCR-12-2726
Zheng, 2013, Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer, PLoS One, 8, e77853, 10.1371/journal.pone.0077853
Kan, 2012, Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer, BMC Cancer, 12, 627, 10.1186/1471-2407-12-627
Hu, 2011, miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8, J Biol Chem, 286, 13714, 10.1074/jbc.M110.204131
Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262
van Meerloo, 2011, Cell sensitivity assays: The MTT assay, Methods Mol Biol, 731, 237, 10.1007/978-1-61779-080-5_20
Han, 2013, MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151, Cell Physiol Biochem, 31, 823, 10.1159/000350100
Song, 2015, MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88, Cell Physiol Biochem, 35, 1167, 10.1159/000373941
Wu, 2014, MiR-4782-3p inhibited non-small cell lung cancer growth via USP14, Cell Physiol Biochem, 33, 457, 10.1159/000358626
Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035
Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res, 19, 92, 10.1101/gr.082701.108
Grimson, 2007, MicroRNA targeting specificity in mammals: Determinants beyond seed pairing, Mol Cell, 27, 91, 10.1016/j.molcel.2007.06.017
Garcia, 2011, Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs, Nat Struct Mol Biol, 18, 1139, 10.1038/nsmb.2115
Grentzmann, 1998, A dual-luciferase reporter system for studying recoding signals, RNA, 4, 479
Xu, 2011, Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer, J Hematol Oncol, 4, 17, 10.1186/1756-8722-4-17
Lv, 2012, Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer, PLoS One, 7, e35065, 10.1371/journal.pone.0035065